Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland W Sutter

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
Heliyon|January 16, 2018
Feasibility of conducting intradermal vaccination campaign with inactivated poliovirus vaccine using Tropis intradermal needle free injection system, Karachi, PakistanMohammad Tahir Yousafzai, Ali Faisal Saleem, Ondrej Mach, et al.
The Journal of Infectious Diseases|December 16, 2003
Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitisNino Khetsuriani, D Rebecca Prevots, Linda Quick, et al.
The Journal of Infectious Diseases|April 7, 2010
Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccinationNicholas C Grassly, Hamid Jafari, Sunil Bahl, et al.
The Journal of Infectious Diseases|January 17, 2019
Poliovirus Type 2 Seroprevalence Following Full- or Fractional-Dose Inactivated Poliovirus Vaccine in the Period After Sabin Type 2 Withdrawal in Sri LankaDeepa Gamage, Ondrej Mach, Samitha Ginige, et al.
MMWR. Morbidity and Mortality Weekly Report|June 23, 2017
Progress Toward Containment of Poliovirus Type 2 - Worldwide, 2017Nicoletta Previsani, Harpal Singh, Jeanette St Pierre, et al.
Heliyon|March 22, 2018
Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in MadagascarRichter Razafindratsimandresy, Ondrej Mach, Jean-Michel Heraud, et al.
Frontiers in Immunology|October 11, 2017
Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization RegistryGrace Macklin, Yi Liao, Marina Takane, et al.
MMWR. Morbidity and Mortality Weekly Report|September 7, 2018
Progress Toward Poliovirus Containment Implementation - Worldwide, 2017-2018Jacqueline Fournier-Caruana, Nicoletta Previsani, Harpal Singh, et al.
Pediatrics|August 8, 2002
Vaccination coverage of foreign-born children 19 to 35 months of age: findings from the National Immunization Survey, 1999-2000Tara W Strine, Lawrence E Barker, Ali H Mokdad, et al.
American Journal of Epidemiology|July 15, 2005
A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the futureRadboud J Duintjer Tebbens, Mark A Pallansch, Olen M Kew, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Heliyon|January 16, 2018
Feasibility of conducting intradermal vaccination campaign with inactivated poliovirus vaccine using Tropis intradermal needle free injection system, Karachi, PakistanMohammad Tahir Yousafzai, Ali Faisal Saleem, Ondrej Mach, et al.
The Journal of Infectious Diseases|December 16, 2003
Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitisNino Khetsuriani, D Rebecca Prevots, Linda Quick, et al.
The Journal of Infectious Diseases|April 7, 2010
Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccinationNicholas C Grassly, Hamid Jafari, Sunil Bahl, et al.
The Journal of Infectious Diseases|January 17, 2019
Poliovirus Type 2 Seroprevalence Following Full- or Fractional-Dose Inactivated Poliovirus Vaccine in the Period After Sabin Type 2 Withdrawal in Sri LankaDeepa Gamage, Ondrej Mach, Samitha Ginige, et al.
MMWR. Morbidity and Mortality Weekly Report|June 23, 2017
Progress Toward Containment of Poliovirus Type 2 - Worldwide, 2017Nicoletta Previsani, Harpal Singh, Jeanette St Pierre, et al.
Heliyon|March 22, 2018
Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in MadagascarRichter Razafindratsimandresy, Ondrej Mach, Jean-Michel Heraud, et al.
Frontiers in Immunology|October 11, 2017
Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization RegistryGrace Macklin, Yi Liao, Marina Takane, et al.
MMWR. Morbidity and Mortality Weekly Report|September 7, 2018
Progress Toward Poliovirus Containment Implementation - Worldwide, 2017-2018Jacqueline Fournier-Caruana, Nicoletta Previsani, Harpal Singh, et al.
Pediatrics|August 8, 2002
Vaccination coverage of foreign-born children 19 to 35 months of age: findings from the National Immunization Survey, 1999-2000Tara W Strine, Lawrence E Barker, Ali H Mokdad, et al.
American Journal of Epidemiology|July 15, 2005
A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the futureRadboud J Duintjer Tebbens, Mark A Pallansch, Olen M Kew, et al.
Pageof 13